Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction
May 19, 2022
Ryan Allway May 19th, 2022 Psychedelics, Top News Entities on track to merge under PSLY.com and list on NASDAQ Stock Exchange MIAMI and MAUI, Hawaii, May 19, 2022 (GLOBE NEWSWIRE) — Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development... Read more
Ryan Allway May 19th, 2022 Psychedelics, Top News PharmAla to supply SABI Mind’s Healing Centres, subject to Health Canada approval VANCOUVER, BC, May 19, 2022 /CNW/ – PharmAla Biotech (CSE: MDMA) is pleased to announce that it has signed an agreement with SABI Mind Inc. which will allow for its GMP... Read more
Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
May 17, 2022
New strains to provide crucial insights in mental health research across the sector May 17, 2022 VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human experiences, is pleased to announce... Read more
Ryan Allway May 12th, 2022 Psychedelics, Top News — Review of Phase I ready BMB-101 and upcoming milestones — — Webcast to be held on May 19, 2022, 4:00pm ET — VANCOUVER, British Columbia, May 12, 2022 (GLOBE NEWSWIRE) — Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”)... Read more
Ryan Allway May 10th, 2022 Psychedelics, Top News Nets CAD$15,480,780 cash in non-dilutive capital Current cash position of approximately CAD$50 million or approximately CAD $1.30 per share with only 38.4 million shares issued Profit realized on the sale of the non-core asset which was acquired by FSD Pharma in... Read more
Ryan Allway May 9th, 2022 Psychedelics, Top News MIAMI, May 09, 2022 (GLOBE NEWSWIRE) — Mycotopia Therapies Inc. (OTC Pink: TPIA), a biopharma company focused on research, technology, and the development of medical psychedelics, and Ei.Ventures Inc., a technology company empowering mental wellness through psychoactive compounds, nutraceuticals and web... Read more
Ryan Allway May 4th, 2022 Psychedelics, Top News Generated record gross revenues of $5.6 million in 2021, representing 124% growth YOY Maintained a strong capital position with $28.8 million of assets, and $6.4 million of liabilities LANGLEY, BC, May 4, 2022 /CNW/ – Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (“Adastra” or the “Company”) is pleased to... Read more
Doseology Accelerates Rollout of Medicinal Mushroom Products with National Distribution
April 22, 2022
Ryan Allway April 22nd, 2022 Psychedelics, Top News VERNON, BC, April 22, 2022 /CNW/ — Doseology Sciences Inc.. (CSE: MOOD) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is excited to announce it has signed a Distribution Agreement with Peak Performance Products Inc. (“Peak”)... Read more
Company Leverages Household Brand Status in Effort to be World’s Largest Chain of Psychedelic Mental Health Clinics
April 18, 2022
Ryan Allway April 18th, 2022 Psychedelics, Top News LOS ANGELES, April 18, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has taken the next step in the execution of its ketamine clinic roll-up strategy – a move the Company... Read more
Psychedelics Company Silo Wellness Announces Financing Commitment of CAD$5,950,000 in Convertible Debentures
April 14, 2022
Ryan Allway April 14th, 2022 Psychedelics, Top News Toronto, Ontario–(Newsfile Corp. – April 14, 2022) – Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K70) (“Silo Wellness” or the “Company“), a leading global psychedelics company, is pleased to announce that Alpha Blue Ocean (“ABO“), is supporting the Company’s growth... Read more
